We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
1854 Media is a multi-award-winning media brand powered by a global community of 2m+ creatives including many influential creators, media & arts institutions. It has been designed to discover and showcase the most talented, established, and emerging photographers, helping brands create imagery that cuts through the noise of 3 billion photos taken daily. Its exhibitions are seen by tens of millions with 90,000+ paid image entries. The company's mission is to become an essential platform for photographers by providing the vital tools they need to succeed. 1854 Media has 70% recurring customers since the last raise, and the company is now raising capital to accelerate growth.
days to go: Expired investment: £379,280
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
days to go: Expired investment: Withheld
Active Needle is a medical device company that aims to prevent the problem of needle placement errors in ultrasound-guided needle interventional procedures. The technology allows for precision needle targeting.
days to go: Expired investment: £147,514
Amplify Music, in association with the Music Managers Forum (MMF), provides UK tax paying investors with the opportunity to invest in the future careers of new and emerging music artists while benefiting from the significant tax advantages available through SEIS. MMF was established in 1992 and is now the largest representative body of artist managers in the world. MMF has over 400 members in the UK and represents over 1,000 of the world’s most successful acts.
days to go: Expired investment: Withheld
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go: Expired investment: Withheld
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go: Expired investment: £1,146,318
Beatstream allows users to listen live to bars, clubs and music venues all around the UK using it's music streaming app that's entirely venue centric. Beatstream also gives artists the opportunity to showcase their music and creativity without having to get people to invest by buying a ticket.
days to go: Expired investment: £32,240
Belluscura aims at attending millions of people worldwide who are suffering from chronic lung diseases by providing them with the X-PLOR, portable, a lightweight, oxygen delivery device. It has developed it mainly to improve both the mobility and the life quality of the patients suffering from Chronic Obstructive Pulmonary Disease globally. It also has an exclusive license to a patented portable oxygen concentrator, the X-PLOR, that supplies 96% pure oxygen to patients 24/7. It's X-PLOR weights only 1.4kg and is 33% lighter, and provides 37% more oxygen per kg than its leading opponents. As smoke, pollution, and lives increase, the oxygen market will continue to grow from £1.1bn to £1.9bn by 2024. So, according to its market research, a 3% market share within 3 years could generate £46m in sales. With the funds raised, it is planning to extend its proprietary oxygen platform technology into other multi £bn markets such as wound care and sleep. Furthermore, it has filed patents on a next-generation portable artificial lung.
days to go: Expired investment: £543,670
Big Couch is the 'crewfunding' platform that empowers filmmakers to connect with crews that invest in projects they believe in. Crews accept lower upfront fees in return for profit shares and deferred payment. Film producers optimise their budgets up to 20%. 
days to go: Expired investment: £403
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go: Expired investment: £451,506
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph